1. Hu, Jialei, Shan, Yujia, Ma, Jia, Jiang, Liqun, Jia, Li. 2019. LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating α-2,3 sialylation via PI3K/Akt signaling. In International journal of cancer, 145, 450-460. doi:10.1002/ijc.32103. https://pubmed.ncbi.nlm.nih.gov/30613961/
2. Li, Jiaxuan, Long, Yiming, Sun, Jingya, Huang, Ruimin, Yan, Jun. 2022. Comprehensive landscape of the ST3GAL family reveals the significance of ST3GAL6-AS1/ST3GAL6 axis on EGFR signaling in lung adenocarcinoma cell invasion. In Frontiers in cell and developmental biology, 10, 931132. doi:10.3389/fcell.2022.931132. https://pubmed.ncbi.nlm.nih.gov/36092699/
3. Glavey, Siobhan V, Manier, Salomon, Natoni, Alessandro, Ghobrial, Irene M, O'Dwyer, Michael E. 2014. The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma. In Blood, 124, 1765-76. doi:10.1182/blood-2014-03-560862. https://pubmed.ncbi.nlm.nih.gov/25061176/
4. Dalangood, Sumiya, Zhu, Zhen, Ma, Zhihui, Yan, Jun, Huang, Ruimin. 2020. Identification of glycogene-type and validation of ST3GAL6 as a biomarker predicts clinical outcome and cancer cell invasion in urinary bladder cancer. In Theranostics, 10, 10078-10091. doi:10.7150/thno.48711. https://pubmed.ncbi.nlm.nih.gov/32929335/
5. Li, Xiaocheng, Xiao, Yaqing, Li, Pengfei, Bian, Huijie, Li, Zheng. 2024. Sialyltransferase ST3GAL6 silencing reduces α2,3-sialylated glycans to regulate autophagy by decreasing HSPB8-BAG3 in the brain with hepatic encephalopathy. In Journal of Zhejiang University. Science. B, 25, 485-498. doi:10.1631/jzus.B2300917. https://pubmed.ncbi.nlm.nih.gov/38910494/